Skip to content

Co-Diagnostics, Inc.: 10-Q filed 2021-11-12

What Co-Diagnostics, Inc. reported in its quarterly report filed 2021-11-12 (fiscal Q3 2021): 41 published measures, 122 facts as tagged in accession 0001493152-21-027937.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-12
Fiscal period
fiscal Q3 2021
Accession
0001493152-21-027937 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Co-Diagnostics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-30105,358,608USD
At 2020-12-3171,237,197USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-305,200,255USD
At 2020-12-314,540,688USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-30100,158,353USD
At 2021-06-3087,265,943USD
At 2021-03-3176,257,476USD
At 2020-12-3166,696,509USD
At 2020-09-3052,776,047USD
At 2020-06-3035,726,862USD
At 2020-03-3119,166,969USD
At 2019-12-311,737,256USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-3082,658,248USD
At 2020-12-3142,976,713USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-3011,475,966USD92
2021-01-01 to 2021-09-3029,160,154USD273
2021-04-01 to 2021-06-309,785,213USD91
2021-01-01 to 2021-03-317,898,975USD90
2020-07-01 to 2020-09-3015,731,532USD92
2020-01-01 to 2020-09-3029,671,348USD274
2020-04-01 to 2020-06-3015,005,009USD91
2020-01-01 to 2020-03-31-1,065,193USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-3036,202,945USD273
2020-01-01 to 2020-09-308,207,340USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-30547,708USD273
2020-01-01 to 2020-09-30305,683USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-3030,101,353USD92
2021-01-01 to 2021-09-3077,484,262USD273
2020-07-01 to 2020-09-3021,818,753USD92
2020-01-01 to 2020-09-3047,407,555USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-30450,398USD273
2020-01-01 to 2020-09-3019,200,067USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,028,192USD273
2020-01-01 to 2020-09-30-7,070,183USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-3046,670,869USD
At 2020-12-3117,510,715USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-3028,941,357shares92
2021-01-01 to 2021-09-3028,800,450shares273
2020-07-01 to 2020-09-3028,084,267shares92
2020-01-01 to 2020-09-3026,172,439shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-3029,952,690shares92
2021-01-01 to 2021-09-3029,872,415shares273
2020-07-01 to 2020-09-3029,597,792shares92
2020-01-01 to 2020-09-3027,621,531shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-300.4USD/shares92
2021-01-01 to 2021-09-301.01USD/shares273
2020-07-01 to 2020-09-300.56USD/shares92
2020-01-01 to 2020-09-301.13USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-300.38USD/shares92
2021-01-01 to 2021-09-300.98USD/shares273
2020-07-01 to 2020-09-300.53USD/shares92
2020-01-01 to 2020-09-301.07USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,100,594USD92
2021-01-01 to 2021-09-306,231,310USD273
2020-07-01 to 2020-09-30-2,914,781USD92
2020-01-01 to 2020-09-30-2,914,781USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-301,524,806USD
At 2020-12-31949,639USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-303,851,293USD273
2020-01-01 to 2020-09-302,167,376USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-3013,630,121USD92
2021-01-01 to 2021-09-3035,756,187USD273
2020-07-01 to 2020-09-3012,038,202USD92
2020-01-01 to 2020-09-3025,664,530USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-30102,287,152USD
At 2020-12-3167,813,209USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-304,119,897USD
At 2020-12-314,510,688USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30800,003USD
At 2020-12-31598,318USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-3014,589,599USD
At 2020-12-3112,136,833USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-3013,159,977USD92
2021-01-01 to 2021-09-3032,639,900USD273
2020-07-01 to 2020-09-303,959,270USD92
2020-01-01 to 2020-09-309,464,699USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-303,302,925USD
At 2020-12-317,995,189USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-3026,790,098USD92
2021-01-01 to 2021-09-3068,396,087USD273
2020-07-01 to 2020-09-3015,997,472USD92
2020-01-01 to 2020-09-3035,129,229USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,311,255USD92
2021-01-01 to 2021-09-309,088,175USD273
2020-07-01 to 2020-09-305,821,281USD92
2020-01-01 to 2020-09-3012,278,326USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,893,350USD92
2021-01-01 to 2021-09-3012,779,573USD273
2020-07-01 to 2020-09-30921,889USD92
2020-01-01 to 2020-09-302,072,160USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-3028,894,890shares
At 2020-12-3128,558,033shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3053,458,589USD
At 2020-12-3149,157,236USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-302,055,698USD
At 2020-12-312,849,503USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2021-09-30189,556USD
At 2020-12-31305,307USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-3013,576,560USD92
2021-01-01 to 2021-09-3035,391,464USD273
2020-07-01 to 2020-09-3012,816,751USD92
2020-01-01 to 2020-09-3026,756,567USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,919,498USD92
2021-01-01 to 2021-09-308,323,620USD273
2020-07-01 to 2020-09-302,203,417USD92
2020-01-01 to 2020-09-305,853,935USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-07-01 to 2021-09-3094,038USD92
2021-01-01 to 2021-09-30232,757USD273
2020-07-01 to 2020-09-3035,490USD92
2020-01-01 to 2020-09-3081,456USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-53,561USD92
2021-01-01 to 2021-09-30-364,723USD273
2020-07-01 to 2020-09-30778,549USD92
2020-01-01 to 2020-09-301,092,037USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-01-01 to 2021-09-3034,672USD273
2020-01-01 to 2020-09-30-2,914,781USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2021-01-01 to 2021-09-304,733,200USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-09-3019,470,005USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-302,608,777USD273
2020-01-01 to 2020-09-3010,509,035USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-4,432,048USD273
2020-01-01 to 2020-09-3010,647,034USD274

Inspect the source

Entity
Co-Diagnostics, Inc. / CIK 0001692415
Captured
2026-09-21T17:25:24.267Z
SEC response SHA-256
0d45d960bb3fa5de76e632ce55df49625cdea1eb0d33ba7dcda1318f7d31930a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001692415.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))